Protection of Human Nasal Respiratory Epithelium from Complement-mediated Lysis by Cell-membrane Regulators of Complement Activation

American Journal of Respiratory Cell and Molecular Biology

Volumn 15, Issue 6, 1996, Pages 731-737

  Varsano, Shabtai ^a   Frolkis, Inna ^b   Rashkovsky, Ludmila ^b   Ophir, Dov ^b   Fishelson, Zvi ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORYCTOLAGUS CUNICULUS;

CD46 PROTEIN, HUMAN; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT INHIBITOR; DECAY ACCELERATING FACTOR; LEUKOCYTE ANTIGEN; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CHILD; CYTOTOXICITY; EPITHELIUM; HUMAN; IMMUNOLOGY; MIDDLE AGED; NOSE MUCOSA; PHYSIOLOGY;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; CELLS, CULTURED; CHILD; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; EPITHELIUM; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NASAL MUCOSA;

EID: 0030338666     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.15.6.8969267     Document Type: Article

References (22)

1. Muller-Eberhard, H. J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321-347.
2. Morgan, B. P. 1989. Mechanisms of tissue damage by the membrane attack complex of complement. Compl. Inflamm. 6:104-111.
3. Andersson, M., L. Michel, J. B. Llull, and U. Pipkora. 1994. The immediate allergic reaction in the nose. Allergy 49:242-245.
4. Bjornson, A. B., M. A. Mellencamp, and G. M. Schiff. 1991. Complement is activated in the upper respiratory tract during influenza virus infection. Am. Rev. Respir. Dis. 143:1062-1066.
5. Fick, R. B., Jr., R. A. Robbins, S. U. Squier, W. E. Schoderbek, and W. D. Russ. 1986. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr. Res. 20:1258-1268.
6. Van de Graaf, E. A., H. M. Jansen, M. M. Bakker, C. Albert, J. K. Eeftinick Schallenkerk, and T. A. Out. 1992. ELISA of complement C3a in bronchoalveolar lavage fluid. J. Immunol. Method 147:241-250.
7. Strunk, R. C., D. M. Eidlen, and R. F. Mason. 1988. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J. Clin. Invest. 81:1419-1426.
8. Persson, C. G. A., and I. Erjefalt. 1986. Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen. Acta Physiol. Scand. 126:615-616.
9. Pangburn, M. K. 1988. Initiation and activation of the alternative pathway of complement. In Cytolytic Lymphocytes and Complement Receptors of the Immune System, Vol. 1. E. R. Podack, editor. CRC Press, Boca Raton, FL. 42-56.
10. Kew, R. R., B. Ghebrehiwet, and A. Janoff. 1985. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J. Clin. Invest. 75:1000-1007.
11. Seya, T., J. Turner, and J. P. Atkinson. 1986. Purification and characterization of a membrane protein (gp 45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163:837-855.
12. Nicholson-Weller, A., J. Burge, D. T. Fearon, R. F. Weller, and K. F. Austen. 1982. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129:184-189.
13. Davies, A., D. L. Simmons, G. Hale, R. A. Harrison, H. Tighe, P. J. Lachmann, and H. Waldmann. 1989. CD59. an Ly-6 like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170: 637-654.
14. Ross, G. D. 1992. Complement receptor type 1. Curr. Top. Microbiol. Immunol. 187:31-34.
15. Varsano, S., I. Frolkis, and D. Ophir. 1995. Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract. Am. J. Respir. Crit. Care Med. 152:1087-1093.
16. Kinoshita, T., M. E. Medof, R. Silber, and V. Nussenzweig. 1985. Distribution of DAF in peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 162:75-92.
17. Iida, K., R. Mornaghi, and V. Nussenzweig. 1982. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 155:1427-1438.
18. Parizade, M., Arnon, P. J. Lachmann, and Z. Fishelson. 1994. Functional and antigenic similarities between a 94-KD protein of Schistoma mansoni (SCIP-1) and human CD59. J. Exp. Med. 179:1625-1636.
19. Shlesinger, M., Z. Nave, Y. Levy, P. E. Slater, and Z. Fishelson. 1990. Prevalence of hereditary properdin, C7, and C8 deficiencies in patients with meningococcal infections. Clin. Exp. Immunol. 81:423-427.
20. Meri, S., H. Waldmann, and P. J. Lachmann. 1991. Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissue. Lab. Invest. 65:532-537.
21. Nose, M., M. Katoh, N. Okada, M. Kyogoku, and H. Okada. 1990. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 70:145-149.
22. Takahiko, S., K. Kojama, T. Hara, Y. Eshita, N. Shibata, M. Matsumoto, T. Seya, and Y. Mori. 1993. Levels of complement regulatory molecules in lung cancer: Disappearance of the D17 epitope of CD55 in small-cell carcinoma. Jpn. J. Cancer Res. 84:753-759.